Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY)

Price 2.85p on 26-04-2024 at 15:49:36
Change 0.00p 0%
Buy 2.90p
Sell 2.80p
Buy / Sell AGY Shares
Last Trade: Sell 34,232.00 at 2.803p
Day's Volume: 515,871
Last Close: 2.85p
Open: 2.85p
ISIN: GB00B02LCQ05
Day's Range 2.85p - 2.85p
52wk Range: 0.85p - 6.25p
Market Capitalisation: £136m
VWAP: 2.873734p
Shares in Issue: 4,766m

Recent Trades History Allergy Thera. (AGY)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 34,232 2.803p Ordinary
15:18:46 - 26-Apr-24
Sell* 130,000 2.822p Ordinary
15:10:03 - 26-Apr-24
Buy* 50 2.89p Ordinary
14:42:09 - 26-Apr-24
Buy* 8,512 2.89p Ordinary
14:41:08 - 26-Apr-24
Buy* 50 2.89p Ordinary
14:40:24 - 26-Apr-24
Buy* 50 2.89p Ordinary
14:39:49 - 26-Apr-24
Sell* 31 2.822p Ordinary
13:19:47 - 26-Apr-24
Unknown* 342,896 2.90p Ordinary
09:13:15 - 26-Apr-24
Buy* 50 2.89p Ordinary
08:10:04 - 26-Apr-24

Share Price History for Allergy Thera.

Time period:
to
Date Open High Low Close Volume

Share News for Allergy Thera.

EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line

27th Mar 2024 16:13

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: Norman Broadbent profit swing on rising revenue

27th Mar 2024 11:02

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

Allergy Therapeutics starts dosing patients in peanut allergy trial

12th Mar 2024 14:06

(Alliance News) - Allergy Therapeutics PLC on Tuesday said it has commenced subcutaneous dosing of peanut allergic patients in its phase 1/2a Protect trial. Read More

UK shareholder meetings calendar - next 7 days

1st Mar 2024 15:49

Read More

Allergy Therapeutics forecasts revenue drop but trials going well

14th Feb 2024 10:22

(Alliance News) - Allergy Therapeutics PLC on Wednesday said revenue decreased in its latest half year, and expects to require further funding soon. Read More

FTSE 100 Latest
Value8,139.83
Change60.97

Login to your account

Forgot Password?

Not Registered